Association between 3D Printing-Assisted Pelvic or Acetabular Fracture Surgery and the Length of Hospital Stay in Nongeriatric Male Adults.
Chun-Chi HungPei-Hung ShenJia-Lin WuYung-Wen ChengWei-Liang ChenShih-Han LeeTsu-Te YehPublished in: Journal of personalized medicine (2022)
Pelvic and acetabular fractures are challenging for orthopedic surgeons, but 3D printing has many benefits in treating these fractures and has been applied worldwide. This study aimed to determine whether 3D printing can shorten the length of hospital stay (LHS) in nongeriatric male adult patients with these fractures. This is a single-center retrospective study of 167 nongeriatric male adult participants from August 2009 to December 2021. Participants were divided into two groups based on whether they received 3D printing assistance. Subgroup analyses were performed. Pearson's correlation and multivariable linear regression models were used to analyze the LHS and the parameters. Results showed that 3D printing-assisted surgery did not affect LHS in the analyzed patients. The LHS was positively correlated with the Injury Severity Score (ISS). Initial hemoglobin levels were negatively associated with LHS in patients aged 18-40 and non-major trauma (ISS < 16) patients. In 40-60-year-old and non-major trauma patients, the duration from fracture to admission was significantly associated with LHS. This study indicates that 3D-assisted technology for pelvic or acetabular fracture surgery for nongeriatric male adults does not influence the LHS. More importantly, the initial evaluation of patients in the hospital was the main predictor of the LHS.
Keyphrases
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- ejection fraction
- healthcare
- minimally invasive
- prognostic factors
- peritoneal dialysis
- randomized controlled trial
- emergency department
- trauma patients
- acute coronary syndrome
- young adults
- patient reported outcomes
- rectal cancer
- clinical trial
- total hip
- adverse drug
- patient reported
- total hip arthroplasty
- open label
- phase iii